Study new HPV vaccine in healthy adults
Treatments studied
Part of Infections clinical trials.
This early study tests a new HPV (human papillomavirus) vaccine to see if it can safely trigger an immune response in healthy adults. It’s for people who have not had an HPV vaccine before and can follow study vaccination and pregnancy-prevention rules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent and follow the study rules and visit schedule
- You are age 18 to 45 when you sign up
- You must use highly effective birth control during the study and for 4 weeks after each shot, unless you cannot become pregnant or will be abstinent
- You cannot get any commercially available HPV vaccine during the study
- You should not have had an HPV vaccine before, and you shouldn’t have had a vaccine in the last 28 days
- No certain medical issues that could make vaccination unsafe or affect your immune response (including some blood test and allergy results)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a single dose of the HPV vaccine is enough to protect against the viruses that cause several cancers. You will have the vaccine and some small tissue samples taken to see how your immune system responds.
This trial tests a new vaccine called V540B that targets HPV, a common virus linked to certain cancers. The study aims to see if the vaccine is safe and produces a strong immune response in healthy people.
This trial tests a new 15-valent HPV vaccine to see if it is safe and creates a strong immune response. If you are between 9 and 45 years old and have not had an HPV vaccine before, you may be able to join.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
This trial tests whether a vaccine against HPV can help prevent pre-cancerous lesions from coming back after you've had them. It's for people who have had high-grade pre-cancerous lesions but haven't yet been treated for them.
This Phase 4 study tests whether a 9-type HPV vaccine (9vHPV) can reduce how infectious HPV is and lower the chance of HPV spreading in women who already have HPV16 and/or HPV18. It focuses on specific HPV-positive women recently diagnosed and compares what happens after vaccination.
Hear when a new HPV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.